Definition and diagnosis of sarcopenia: Asia-Pacific perspectives
Osteoporosis and Sarcopenia · 2025-06 · 11 (2) · 2-10
DOI: 10.1016/j.afos.2025.05.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Osteoporosis and Sarcopenia, 2025-06. Verfasst von Wei-Fu Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chi Mei Medical Center.
Abstract (Originalsprache)
Sarcopenia is a progressive, age-related condition characterized by the loss of skeletal muscle mass, strength, and function. As Asia faces rapid population aging, sarcopenia has become an urgent public health concern. Over time, definitions and diagnostic criteria have evolved to emphasize muscle strength and physical performance rather than muscle mass alone. This review summarizes key updates in global and regional frameworks, including guidelines from the European Working Group on Sarcopenia in Older People (EWGSOP2) and the Asian Working Group for Sarcopenia (AWGS 2019). However, these strategies might be updated along with the release of AWGS 2025. We also review current methods for evaluating muscle health. Although dual-energy X-ray absorptiometry (DXA) remains a standard, it has limitations in reflecting true muscle quality and predicting outcomes. Novel techniques like deuterium-labeled creatine dilution show promise for more accurate assessment. The review highlights emerging muscle-related biomarkers-myokines such as interleukin-6 (IL-6), insulin-like growth factor-1 (IGF-1), irisin, myostatin, and gelsolin-which may improve diagnostic precision and therapeutic strategies. The Global Leadership Initiative on Sarcopenia (GLIS) introduced the first globally endorsed definition, incorporating muscle mass, strength, muscle-specific strength, and physical performance as a key outcome in 2024. This unified approach supports standardized diagnosis across clinical and research settings. Addressing sarcopenia alongside other age-related conditions is essential to prevent frailty and disability. Finally, the targeted multidomain interventions-particularly physical activity and nutrition-are critical for preserving function and quality of life in older adults.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
- Department of Family Medicine, Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan.
- Department of Family Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Institute of Gerontology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Family Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Förderung
- Chi Mei Medical Center
Zitieren
APA
Huang, W. F., Chen, Y. C., Chang, C. S., & Wu, C. H. (2025). Definition and diagnosis of sarcopenia: Asia-Pacific perspectives. Osteoporosis and Sarcopenia, 11(2), 2-10. https://doi.org/10.1016/j.afos.2025.05.004
Vancouver
Huang WF, Chen YC, Chang CS, Wu CH. Definition and diagnosis of sarcopenia: Asia-Pacific perspectives. Osteoporosis and Sarcopenia. 2025;11(2):2-10. doi:10.1016/j.afos.2025.05.004
BibTeX
@article{Huang2025,
author = {Huang, Wei-Fu and Chen, Ying-Chen and Chang, Chin-Sung and Wu, Chih-Hsing},
title = {Definition and diagnosis of sarcopenia: Asia-Pacific perspectives},
journal = {Osteoporosis and Sarcopenia},
year = {2025},
volume = {11},
number = {2},
pages = {2--10},
doi = {10.1016/j.afos.2025.05.004}
}
EUVIMED